All-trans retinoic acid diminishes collagen production in a hepatic stellate cell line via suppression of active protein-1 and c-Jun N-terminal kinase signal

Abstract

Following acute and chronic liver injury, hepatic stellate cells (HSCs) become activated to undergo a phenotypic transformation into myofibroblast-like cells and lose their retinol content, but the mechanisms of retinoid loss and its potential roles in HSCs activation and liver fibrosis are not understood. The influence of retinoids on HSCs and hepatic fibrosis remains controversial. The purpose of this study was to evaluate the effects of all-trans retinoid acid (ATRA) on cell proliferation, mRNA expression of collagen genes [procollagen α1 (I), procollagen α1 (III)], profibrogenic genes (TGF-β₁, CTGF, MMP-2, TIMP-1, TIMP-2, PAI-1), fibrolytic genes (MMP-3, MMP-13) and the upstream element (JNK and AP-1) in the rat hepatic stellate cell line (CFSC-2G). Cell proliferation was evaluated by measuring BrdU incorporation. The mRNA expression levels of collagen genes [procollagen α1 (I), procollagen α1 (III)], profibrogenic genes (TGF-β₁, CTGF, MMP-2, TIMP-1, TIMP-2, PAI-1), and fibrolytic genes (MMP-3, MMP-13) were quantitatively detected by using real-time PCR. The mRNA expression of JNK and AP-1 was quantified by RT-PCR. The results showed that ATRA inhibited HSCs proliferation and diminished the mRNA expression of collagen genes [procollagen α1 (I), procollagen α1 (III)] and profibrogenic genes (TGF-β₁, CTGF, MMP-2, TIMP-1, TIMP-2, PAI-1), and significantly stimulated the mRNA expression of MMP-3 and MMP-13 in HSCs by suppressing the mRNA expression of JNK and AP-1. These findings suggested that ATRA could inhibit proliferation and collagen production of HSCs via the suppression of active protein-1 and c-Jun N-terminal kinase signal, then decrease the mRNAs expression of profibrogenic genes (TGF-β₁, CTGF, MMP-2, TIMP-1, TIMP-2, PAI-1), and significantly induce the mRNA expression of MMP-3 and MMP-13.

Keywords

all trans-retinoic acid / liver stellate cells / collagen / transforming growth factor β₁ / active protein-1 / c-Jun N-terminal kinase

References

[1] FriedmanS.L.. The cellular basis of hepatic fibrosis. N Engl J Med, 1993, 24328(25): 1828-1835

[2] HautekeeteM.L., GeertsA.. The hepatic stellate (Ito) cell: its role in human liver disease. Virchows Arch, 1997, 430(3): 195-207

[3] FriedmanS.L.. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem, 2000, 275(4): 2247-2250

[4] OhataM., LinM., SatreM., et al.. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol, 1997, 272(3Pt1): G589-596

[5] FriedmanS.L., WeiS., BlanerW.S.. Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol, 1993, 264(5Pt1): G947-952

[6] GudasL.J., SpornM.B., RobertsA.B.. SpornM.B., RobertsA.B., GoodmanD.S.. Cellular biology and biochemistry of the retinoids. The Retinoids. Biology, Chemistry, and Medicine, 19942nd ed.New York, Raven Press, 443-520

[7] ChambonP.. A decade of molecular biology of retinoic acid receptors. FASEB J, 1996, 10(9): 940-954

[8] DavisB.H., KramerR.T., DavidsonN.O.. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest, 1990, 86(6): 2062-2070

[9] ChiX., AnselmiK., WatkinsS., et al.. Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid. Br J Pharmacol, 2003, 139(4): 765-774

[10] DavisB.H., VucicA.. The effect of retinol on Ito cell proliferation in vitro. Hepatology, 1988, 8(4): 788-793

[11] MargisR., Pinheiro-MargisM., da SilvaL.C., et al.. Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX). Int J Exp Pathol, 1992, 73(2): 125-135

[12] PinzaniM., GentiliniP., AbboudH.E.. Phenotypical modulation of liver fat-storing cells by retinoids. Influence on unstimulated and growth factor-induced cell proliferation. J Hepatol, 1992, 14(2–3): 211-220

[13] SenooH., WakeK.. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest, 1985, 52(2): 182-194

[14] SeifertW.F., BosmaA., HendriksH.F., et al.. Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats. Liver, 1995, 15(1): 1-8

[15] MizobuchiY., ShimizuI., YasudaM., et al.. Retinyl palmitate reduces hepatic fibrosis in rats induced by dimethylnitrosamine or pig serum. J Hepatol, 1998, 29(6): 933-943

[16] OkunoM., MutoY., MoriwakiH., et al.. Inhibitory effect of acyclic retinoid (polyprenoic acid) on hepatic fibrosis in CCl₄-treated rats. Gastroenterol Jpn, 1990, 25(2): 223-229

[17] SeifertW.F., BosmaA., BrouwerA., et al.. Vitamin A deficiency potentiates carbon tetrachloride-induced liver fibrosis in rats. Hepatology, 1994, 19(1): 193-201

[18] OkunoM., MoriwakiH., ImaiS., et al.. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology, 1997, 26(4): 913-921

[19] OkunoM., SatoT., KitamotoT., et al.. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo. J Hepatol, 1999, 30(6): 1073-1080

[20] LeoM.A., LieberC.S.. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat. Hepatology, 1983, 3(1): 1-11

[21] DanZ.L., PopovY., PatsenkerE., et al.. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J, 2005, 19(7): 845-847

[22] PanZ.H., DanZ.L., Fuyu, et al.. Low-dose ATRA supplementation abolishes PRM formation in rat liver and ameliorates ethanol-induced liver jnjury. J Huazhong Univ Sci Technol [Med Sci], 2006, 26(5): 508-512

[23] HellemansK., VerbuystP., QuartierE., et al.. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology, 2004, 39(1): 97-108

[24] PinzaniM., MarraF.. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis, 2001, 21(3): 397-416

[25] WangL., TankersleyL.R., TangM., et al.. Regulation of alpha 2(I) collagen expression in stellate cells by retinoic acid and retinoid X receptors through interactions with their cofactors. Arch Biochem Biophys, 2004, 428(1): 92-98

[26] RachfalA.W., BrigstockD.R.. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res, 2003, 26(1): 1-9

[27] FuY., DanZ.L., TangW.X., et al.. Effect of all-trans retinoic acid on expression of TGF-b1, CTGF and Colla1 in chronic alcoholic liver disease in rats. World Chin J Digestol, 2006, 14(2): 179-183

[28] JiangH.Y., DanZ.L., WangH., et al.. Effect of ATRA on contents of liver retinoids, oxidative stress and hepatic injury in rat model of extrahepatic cholestasis. J Huazhong Uni Sci Technol [Med Sci], 2007, 27(5): 1-4

[29] GreenwelP., RubinJ., SchwartzM., et al.. Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest, 1993, 69(2): 210-216

[30] ShekF.W., BenyonR.C.. How can transforming growth factor beta be targeted usefully to combat liver fibrosis?. Eur J Gastroenterol Hepatol, 2004, 16(2): 123-126

[31] OhataM., LinM., SatreM., et al.. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol, 1997, 272(3Pt1): G589-596

[32] JasterR., HilgendorfI., FitznerB., et al.. Regulation of pancreatic stellate cell function in vitro: biological and molecular effects of all-trans retinoic acid. Biochem Pharmacol, 2003, 66(4): 633-641

[33] WilmerW.A., CosioF.G.. DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations. Kidney Int, 1998, 53(5): 1172-1181

[34] UtsugiM., DobashiK., IshizukaT., et al.. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol, 2003, 28(6): 754-761

[35] HashimotoS., GonY., TakeshitaI., et al.. Transforming growth factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med, 2001, 163(1): 152-157

[36] ShinozakiY., SatoY., KoizumiS., et al.. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase. Neuroscience, 2007, 147(1): 153-163

[37] BenkoussaM., BrandC., DelmotteM.H., et al.. Retinoic acid receptors inhibit AP1 activation by regulating extracellular signal-regulated kinase and CBP recruitment to an AP1-responsive promoter. Mol Cell Biol, 2002, 22(13): 4522-4534